Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians

Condition(s) studied

Investigational drug(s) / intervention(s)

Digital Health Intervention: Access to a digital platform including weekly workout videos, live workouts, recipes, study summaries, and a consultation hour.

Study summary

Congenital heart disease (CHD) affects approximately 1% of live births, and children with CHD often fail to meet WHO physical activity guidelines. Digital interventions to promote physical activity in CHD patients are limited. This study will develop and test a 12-week digital lifestyle intervention for children (ages 8-13) and their guardians, using a Garmin Vivofit Jr. 2 wearable to continuously monitor physical activity (PA). We will assess its impact on children's moderate to vigorous intensity physical activity (MVPA), daily activity (steps per day), quality of life, nutrition, and health literacy, as well as the quality of life and health literacy of their parents.

Eligibility

Primary outcome measure(s)

• Physical activity — 12 weeks
  Physical activity is objectively assessed with the wrist worn wearable "Garmin vivofit jr. 2". Daily physical activity is measured on the basis of active minutes in moderate-to-vigorous intensity.

Trial sites (1)

More Deutsches Herzzentrum Muenchen trials in Germany

Other trials for the same condition